Source: Will Michaels, WUNC, 10/8/20


Doctors at UNC-Chapel Hill say early studies of monoclonal antibody therapies show promising results in treating COVID-19. Monoclonal antibodies can be synthetically produced and theoretically help patients' immune systems fight the virus. UNC is one of the institutions participating in a nationwide study of COVID-19 therapeutics. Dr. David Wohl helps lead the respiratory diagnostic center at UNC Hospitals. He said the goal of developing these treatments is to safely give them to people in outpatient settings.

For more of this story, click here.